vs

Side-by-side financial comparison of Five9, Inc. (FIVN) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

Five9, Inc. is the larger business by last-quarter revenue ($300.3M vs $197.9M, roughly 1.5× REPLIGEN CORP). On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 7.8%). Five9, Inc. produced more free cash flow last quarter ($77.3M vs $17.6M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 10.3%).

Five9, Inc. is a leading global provider of cloud-native contact center software and solutions. It serves enterprises of all sizes across retail, healthcare, financial services, and technology sectors, offering omnichannel customer engagement tools, AI-powered automation, workforce management, and analytics to boost customer experience and operational efficiency.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

FIVN vs RGEN — Head-to-Head

Bigger by revenue
FIVN
FIVN
1.5× larger
FIVN
$300.3M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+5.9% gap
RGEN
13.6%
7.8%
FIVN
More free cash flow
FIVN
FIVN
$59.8M more FCF
FIVN
$77.3M
$17.6M
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
10.3%
FIVN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FIVN
FIVN
RGEN
RGEN
Revenue
$300.3M
$197.9M
Net Profit
$13.3M
Gross Margin
55.4%
52.5%
Operating Margin
6.6%
9.0%
Net Margin
6.7%
Revenue YoY
7.8%
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.22
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FIVN
FIVN
RGEN
RGEN
Q4 25
$300.3M
$197.9M
Q3 25
$285.8M
$188.8M
Q2 25
$283.3M
$182.4M
Q1 25
$279.7M
$169.2M
Q4 24
$278.7M
$174.1M
Q3 24
$264.2M
$154.9M
Q2 24
$252.1M
$154.1M
Q1 24
$247.0M
$151.3M
Net Profit
FIVN
FIVN
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$18.0M
$14.9M
Q2 25
$1.2M
$14.9M
Q1 25
$576.0K
$5.8M
Q4 24
$-30.3M
Q3 24
$-4.5M
$-654.0K
Q2 24
$-12.8M
$3.3M
Q1 24
$-7.1M
$2.1M
Gross Margin
FIVN
FIVN
RGEN
RGEN
Q4 25
55.4%
52.5%
Q3 25
55.0%
53.2%
Q2 25
54.9%
50.0%
Q1 25
55.0%
53.6%
Q4 24
56.0%
26.1%
Q3 24
53.8%
50.0%
Q2 24
53.0%
49.8%
Q1 24
53.6%
49.5%
Operating Margin
FIVN
FIVN
RGEN
RGEN
Q4 25
6.6%
9.0%
Q3 25
5.6%
8.9%
Q2 25
-0.6%
7.6%
Q1 25
-1.9%
3.9%
Q4 24
1.5%
-17.7%
Q3 24
-5.8%
-5.1%
Q2 24
-7.7%
1.0%
Q1 24
-8.4%
1.3%
Net Margin
FIVN
FIVN
RGEN
RGEN
Q4 25
6.7%
Q3 25
6.3%
7.9%
Q2 25
0.4%
8.2%
Q1 25
0.2%
3.4%
Q4 24
-17.4%
Q3 24
-1.7%
-0.4%
Q2 24
-5.1%
2.2%
Q1 24
-2.9%
1.4%
EPS (diluted)
FIVN
FIVN
RGEN
RGEN
Q4 25
$0.22
$0.24
Q3 25
$0.21
$0.26
Q2 25
$0.01
$0.26
Q1 25
$0.01
$0.10
Q4 24
$0.16
$-0.55
Q3 24
$-0.06
$-0.01
Q2 24
$-0.17
$0.06
Q1 24
$-0.10
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FIVN
FIVN
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$232.1M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$785.8M
$2.1B
Total Assets
$1.8B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FIVN
FIVN
RGEN
RGEN
Q4 25
$232.1M
$767.6M
Q3 25
$193.4M
$748.7M
Q2 25
$205.5M
$708.9M
Q1 25
$370.3M
$697.2M
Q4 24
$362.5M
$757.4M
Q3 24
$291.0M
$784.0M
Q2 24
$175.7M
$809.1M
Q1 24
$240.2M
$780.6M
Total Debt
FIVN
FIVN
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
FIVN
FIVN
RGEN
RGEN
Q4 25
$785.8M
$2.1B
Q3 25
$775.3M
$2.1B
Q2 25
$717.4M
$2.1B
Q1 25
$664.3M
$2.0B
Q4 24
$622.2M
$2.0B
Q3 24
$565.6M
$2.0B
Q2 24
$525.9M
$2.0B
Q1 24
$483.6M
$2.0B
Total Assets
FIVN
FIVN
RGEN
RGEN
Q4 25
$1.8B
$2.9B
Q3 25
$1.8B
$2.9B
Q2 25
$1.7B
$2.9B
Q1 25
$2.1B
$2.9B
Q4 24
$2.1B
$2.8B
Q3 24
$2.0B
$2.8B
Q2 24
$1.9B
$2.9B
Q1 24
$1.9B
$2.8B
Debt / Equity
FIVN
FIVN
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FIVN
FIVN
RGEN
RGEN
Operating Cash FlowLast quarter
$83.6M
$25.7M
Free Cash FlowOCF − Capex
$77.3M
$17.6M
FCF MarginFCF / Revenue
25.8%
8.9%
Capex IntensityCapex / Revenue
2.1%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$201.2M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FIVN
FIVN
RGEN
RGEN
Q4 25
$83.6M
$25.7M
Q3 25
$59.2M
$48.1M
Q2 25
$35.1M
$28.6M
Q1 25
$48.4M
$15.0M
Q4 24
$49.8M
$39.2M
Q3 24
$41.1M
$49.3M
Q2 24
$19.9M
$42.2M
Q1 24
$32.4M
$44.7M
Free Cash Flow
FIVN
FIVN
RGEN
RGEN
Q4 25
$77.3M
$17.6M
Q3 25
$48.7M
$43.4M
Q2 25
$31.6M
$21.5M
Q1 25
$43.7M
$11.4M
Q4 24
$40.5M
$33.6M
Q3 24
$26.7M
$42.3M
Q2 24
$13.1M
$37.4M
Q1 24
$20.4M
$36.4M
FCF Margin
FIVN
FIVN
RGEN
RGEN
Q4 25
25.8%
8.9%
Q3 25
17.0%
23.0%
Q2 25
11.1%
11.8%
Q1 25
15.6%
6.8%
Q4 24
14.5%
19.3%
Q3 24
10.1%
27.3%
Q2 24
5.2%
24.3%
Q1 24
8.3%
24.0%
Capex Intensity
FIVN
FIVN
RGEN
RGEN
Q4 25
2.1%
4.1%
Q3 25
3.7%
2.5%
Q2 25
1.2%
3.9%
Q1 25
1.7%
2.1%
Q4 24
3.3%
3.2%
Q3 24
5.4%
4.5%
Q2 24
2.7%
3.1%
Q1 24
4.8%
5.5%
Cash Conversion
FIVN
FIVN
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.29×
3.23×
Q2 25
30.38×
1.92×
Q1 25
84.00×
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons